What does Exevir Bio do?
ExeVir Bio is a biotechnology company focused on developing innovative therapies against viral infections. The company specializes in the use of its proprietary technology to create monoclonal antibodies that target and neutralize viruses. ExeVir Bio aims to address urgent medical needs in infectious diseases through its advanced research and development efforts.
- Signals
-
Reporting lossesReporting losses € -1.94M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -1.60MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.63MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 3.67MStrong equity provides a buffer against setbacks.
Low riskLow risk 97.7%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 15.86A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Healthy social debtHealthy social debt 0.0%Social debts stay manageable relative to personnel costs.
- Shareholders
- Fund+ 19,02%, Ucb Biopharma 17,89%, Societe Federale De Participations Et D'investissement 13,42%, +1 more
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
-1.17M
|
€
939K
|
€
2.27M
|
€
11.91M
|
|
|
€
-1.63M
|
€
-457K
|
€
-229K
|
€
10.31M
|
|
|
€
-1.94M
|
€
-4.82M
|
€
-5.26M
|
€
-1.73M
|
|
|
€
3.67M
|
€
5.62M
|
€
10.44M
|
€
15.70M
|
|
|
97.71%
|
85.98%
|
82.61%
|
83.61%
|
|
|
€
86K
|
€
916K
|
€
2.20M
|
€
3.08M
|
|
|
€
926K
|
€
3.19M
|
€
7.91M
|
€
11.02M
|
Publications 10
All publications- Ontslagen - Benoemingen 07/06/2024
- Ontslagen - Benoemingen 12/04/2024
- Maatschappelijke Zetel 19/12/2023
- Ontslagen - Benoemingen 13/07/2022
- Ontslagen - Benoemingen 21/02/2022
Frequently asked questions
Answers to the most common questions about Exevir Bio, based on official government data and the filed annual accounts.
What is the VAT number of Exevir Bio?
The VAT number of Exevir Bio is BE0750.495.334.
When was Exevir Bio established?
Exevir Bio was founded in 10-07-2020.
What is the official address of Exevir Bio?
The official address of Exevir Bio is Technologiepark-Zwijnaarde 94 Gent 9052.
What is the legal form of Exevir Bio?
The juridical form of Exevir Bio is Private limited company (BV/SRL).
What is the annual revenue of Exevir Bio?
The 2025 accounts of Exevir Bio do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Exevir Bio do?
ExeVir Bio is a biotechnology company focused on developing innovative therapies against viral infections. The company specializes in the use of its proprietary technology to create monoclonal antibodies that target and neutralize viruses. ExeVir Bio aims to address urgent medical needs in infectious diseases through its advanced research and development efforts.
Is Exevir Bio a reliable company?
Exevir Bio is a registered Rechtspersoon with company number 0750.495.334 and can be verified through the official CBE database.
What is the credit limit of Exevir Bio?
The estimated credit limit of Exevir Bio is €179,037.
Is Exevir Bio still active?
Exevir Bio currently has the status "Normal situation" and is active.